Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: ASAIO J. 2013 Jan;59(1):63–68. doi: 10.1097/MAT.0b013e318279854a

Fig. 2.

Fig. 2

Correlation of simultaneously measured activated clotting time (ACT) and anti-factor Xa.

Agreement for clinically meaningful values was defined as: ACT <180 s corresponding to anti-factor Xa <0.3 IU/mL, ACT 180–220 s corresponding to anti-factor Xa 0.3–0.7 IU/mL and ACT >220 s corresponding to anti-factor Xa >0.7 IU/mL. Shaded areas represent agreement between ACT and anti-factor Xa, seen in only 42% of measurements. Longitudinal linear regression: y = 218.5+7.2x, p = 0.251, r = −0.02.